CAT
Caterpillar Inc.
CAT has the edge over PAMT overall, supported by stronger fundamentals and lower modeled downside.
PAMT
Pamt Corp.
PAMT offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
PAMT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Weak |
PAMT's revenue is currently healthy, but its profitability, cash flow and balance sheet are under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
PAMT PE Valuation
PAMT has no meaningful PE right now: it lost money over the past year.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
PAMT Forward outlook
There aren't enough analyst estimates for PAMT to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over PAMT on earnings quality, reporting a profit while its opponent remains loss making.
PAMT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.12 | +$0.42 |
| Q2 2026 | -$2.01 | +$0.15 |
| Q1 2026 | -$2.11 | -$0.28 |
| Q4 2025 | -$2.48 | -$1.03 |
| Q3 2025 | -$2.54 | -$2.43 |
| Q2 2025 | -$2.16 | -3700% |
| Q1 2025 | -$1.83 | -400% |
| Q4 2024 | -$1.45 | -275% |
PAMT is still losing money, but less than at its worst: $2.12 per share over the past year, against $2.54 at its worst in late 2025.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over PAMT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over PAMT on profitability, with a higher operating margin.
PAMT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $162.5M | +8.2% |
| Q2 2026 | $164.7M | +8.9% |
| Q1 2026 | $141.9M | -8.7% |
| Q4 2025 | $141.3M | -15% |
| Q3 2025 | $150.3M | -18% |
| Q2 2025 | $151.1M | -17% |
| Q1 2025 | $155.3M | -15% |
| Q4 2024 | $166.5M | -7.6% |
PAMT's revenue is recovering but still below its 2022 peak: $163M last quarter, up 8.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -3.1% | +0.7 points |
| Q2 2026 | -6.3% | +1 points |
| Q1 2026 | -0.2% | +5.7 points |
| Q4 2025 | -27% | -4.3 points |
| Q3 2025 | -3.8% | -5.1 points |
| Q2 2025 | -7.3% | -6.9 points |
| Q1 2025 | -5.9% | -5.5 points |
| Q4 2024 | -23% | -22 points |
PAMT's operating margin was −3.1% last quarter, up 0.7 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over PAMT on cash generation, producing positive trailing cash flow while its opponent burns cash.
PAMT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.1M | -264% |
| Q2 2026 | -$18.4M | -414% |
| Q1 2026 | -$17.1M | -$10.3M |
| Q4 2025 | -$25M | +$15M |
| Q3 2025 | $2.5M | +$36.1M |
| Q2 2025 | $5.9M | +44% |
| Q1 2025 | -$6.8M | +$5.4M |
| Q4 2024 | -$39.9M | -396% |
PAMT has burned cash in six of the last eight quarters: −$65M over the past year, against −$38M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over PAMT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
PAMT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -4K shares |
| 1 year | +0.1% | +13K shares |
| 3 years | -5.4% | -1.2M shares |
| 5 years | -8.4% | -1.9M shares |
| Available history | -9% | -2.1M shares |
PAMT has 21M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $170,000 |
| Q2 2026 | $37,000 |
| Q1 2026 | $11,000 |
| Q4 2025 | — |
| Q3 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | $5.3M |
PAMT has spent almost nothing on buybacks in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over PAMT on leverage, with a lower net debt burden relative to earnings.
PAMT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 13.6x | High |
| Q2 2026 | 13.6x | High |
| Q1 2026 | 11.3x | High |
| Q4 2025 | 15.5x | High |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 4.4x | High |
| Q4 2024 | 4.1x | High |
PAMT's net debt is about 14 years of its operating earnings (EBITDA), up from 6.2 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PAMT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.8 | Neutral |
| Stochastic | 46.9 | Neutral |
PAMT's weekly RSI is 57 (neutral) and its Stochastic is 47 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
PAMT PE vs Industrials Sector
| Metric | PAMT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
PAMT has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
PAMT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.4 | 15% above |
| 20 week MA | $13.1 | 8.4% above |
| 50 week MA | $11.9 | 20% above |
| 100 week MA | $12.5 | 14% above |
| 200 week MA | $16.7 | 15% below |
PAMT has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
PAMT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.3 | $11.1 | -23% |
| 2021 | $11.1 | $32.9 | +197% |
| 2022 | $32.9 | $25.4 | -23% |
| 2023 | $25.4 | $20.8 | -18% |
| 2024 | $20.8 | $17.0 | -18% |
| 2025 | $17.0 | $12.5 | -26% |
| 2026 YTD | $12.5 | $14.2 | +14% |
PAMT has the edge over CAT on returns for 2026, with the stronger performance.